Invention Grant
- Patent Title: Insulin derivatives and the medical uses hereof
-
Application No.: US15121206Application Date: 2015-02-26
-
Publication No.: US10040839B2Publication Date: 2018-08-07
- Inventor: Peter Madsen , Susanne Hostrup , Martin Muenzel , Thomas Boerglum Kjeldsen , Claudia Ulrich Hjoerringgaard , Christian Fledelius
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Rosemarie R. Wilk-Orescan
- Priority: EP14157215 20140228
- International Application: PCT/EP2015/053989 WO 20150226
- International Announcement: WO2015/128403 WO 20150903
- Main IPC: A61K38/28
- IPC: A61K38/28 ; C07K14/62 ; A61K47/22 ; A61K38/00
Abstract:
The present invention is in the therapeutic fields of drugs for medical conditions relating to diabetes. More specifically the invention relates to novel acylated derivatives of human insulin analogues. The invention also provides pharmaceutical compositions comprising such insulin derivatives, and relates to the use of such derivatives for the treatment or prevention of medical conditions relating to diabetes.
Public/Granted literature
- US20170008945A1 Novel Insulin Derivatives and the Medical Uses Hereof Public/Granted day:2017-01-12
Information query
IPC分类:
